# Rebamipide AND Sjögren Syndrome

> **NCT01759108** · NA · UNKNOWN · sponsor: **University of Alexandria** · enrollment: 55 (estimated)

## Conditions studied

- Improving Symptoms of Dry Mouth in Sjőgren's Syndrome

## Interventions

- **DRUG:** Rebamipide

## Key facts

- **NCT ID:** NCT01759108
- **Lead sponsor:** University of Alexandria
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-13
- **Primary completion:** 2021-09
- **Final completion:** 2021-09
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2020-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01759108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01759108, "Rebamipide AND Sjögren Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01759108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*